Systems and methods for visualizing ablated tissue

Patent metadata

Field	Value
Publication number	US-11559192-B2
Application number	US-202016879929-A
Country	US
Kind code	B2
Filing date	May 21, 2020
Priority date	Sep 22, 2011
Publication date	Jan 24, 2023
Grant date	Jan 24, 2023

Abstract

Systems and methods for visualizing ablated tissue are disclosed. In some embodiments, a system for imaging tissue comprising: a catheter having a distal end and a proximal end; an inflatable balloon disposed about the distal end of the catheter; and an optical housing extending from the distal end of the catheter into the balloon, the optical housing being configured to position inside the balloon a light source for illuminating a tissue outside the balloon and a camera for imaging the illuminated tissue.

First claim

What is claimed is:

1. A system for imaging tissue, the system being configured for use in connection with tissue ablation, comprising:
a light source providing light for illuminating a tissue having at least one wavelength sufficient to excite mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) in the tissue;
a sensor for detecting NADH fluorescence from the illuminated tissue, the sensor being configured to receive light having at least one wavelength to detect the NADH fluorescence from the illuminated tissue; and
a processor programmed to perform the steps of:
obtaining the detected NADH fluorescence from the sensor during ablation of the tissue,
generating a digital representation of the detected NADH fluorescence for monitoring a progression of the ablation of the tissue, and
while the tissue is being ablated, determining a decrease in the detected NADH fluorescence and updating the digital representation to show the measured decrease in the detected NADH fluorescence that is indicative of the progression of the ablation of the tissue to enable a user to determine the need for further ablation while the tissue is being ablated.

2. The system of claim 1 , wherein the light for illuminating the tissue has at least one wavelength between about 300 nm and 400 nm.

3. The system of claim 1 , wherein the sensor is configured to receive light having at least one wavelength between about 435 nm and about 485 nm.

4. The system of claim 1 , further comprising an ablation device, the ablation device having an energy source selected from the group consisting of radiofrequency energy, microwave energy, electrical energy, electromagnetic energy, cryoenergy, laser energy, ultrasound energy, acoustic energy, chemical energy, and thermal energy.

5. The system of claim 4 , further comprising an elongate body, and wherein the ablation device is disposed at a distal end of the elongate body.

6. The system of claim 5 , further comprising an irrigation port configured to deliver a fluid to the distal end of the elongate body.

7. The system of claim 1 , wherein the tissue is one of skeletal muscle, liver tissue, kidney tissue, and cardiac tissue.

8. The system of claim 1 , further comprising one or more optical fibers to deliver the light from the light source to the tissue and to deliver the NADH fluorescence to the sensor.

9. A system for imaging tissue comprising:
an ablation device for ablating a tissue;
a light source providing light for illuminating the tissue to excite mitochondrial nicotinamide adenine dinucleotide hydrogen (NADH) in the tissue, wherein the light from the light source has at least one wavelength between about 300 nm and about 400 nm sufficient for NADH excitation;
a sensor being configured to receive light to detect NADH fluorescence from the illuminated tissue; and
a processor programmed to perform the steps of:
obtaining the detected NADH fluorescence from the sensor during ablation of the tissue using the ablation device,
generating a digital representation of the detected NADH fluorescence for monitoring a progression of the ablation of the tissue, wherein a decrease in the detected NADH fluorescence from the illuminated tissue is indicative of the progression of the ablation of the tissue to enable a user to determine the need for further ablation, and
while the tissue is being ablated, determining a decrease in the detected NADH fluorescence and updating the digital representation to show the measured decrease in the detected NADH fluorescence throughout the ablation of the tissue.

10. The system of claim 9 , further comprising an elongate body, the elongate body having the ablation device and an inflatable balloon disposed about a distal end of the elongate body.

11. The system of claim 9 , wherein the ablation device has an energy source selected from the group consisting of radiofrequency energy, microwave energy, electrical energy, electromagnetic energy, cryoenergy, laser energy, ultrasound energy, acoustic energy, chemical energy, and thermal energy.

12. The system of claim 9 , wherein the light source is a UV light emitting diode (LED).

13. The system of claim 9 , wherein the sensor is configured to convert an optical image into an electronic signal.

14. The system of claim 9 , further comprising one or more optical fibers to deliver the light from the light source to the tissue and to deliver the NADH fluorescence to the sensor.

15. The system of claim 9 , further comprising a first light source and a second light source capable of generating light of a different wavelength than the first light source.

16. The system of claim 9 , wherein the tissue is one of skeletal muscle, liver tissue, kidney tissue, or cardiac tissue.

17. A method for imaging tissue comprising:
obtaining detected NADH fluorescence from a sensor during ablation of a tissue using an ablation device,
generating a digital representation of the detected NADH fluorescence for monitoring a progression of the ablation of the tissue, wherein a decrease in the detected NADH fluorescence from the illuminated tissue is indicative of the progression of the ablation of the tissue, and
while the tissue is being ablated, determining a decrease in the detected NADH fluorescence and updating the digital representation to show the measured decrease in the detected NADH fluorescence that is indicative of the progression of the ablation of the tissue to enable a user to determine the need for further ablation.

18. The method of claim 17 , further one or more optical fibers are employed to deliver the light from the light source to the tissue and to deliver the NADH fluorescence to the sensor.

19. The method of claim 17 , wherein the ablating is performed with radiofrequency energy, microwave energy, electrical energy, electromagnetic energy, cryoenergy, laser energy, ultrasound energy, acoustic energy, chemical energy, and thermal energy.

20. The method of claim 17 , wherein the tissue is one of skeletal muscle, liver tissue, kidney tissue, or cardiac tissue.

Assignees

• Univ George Washington
• 460Medical Inc

Inventors

• Amirana Omar
• Armstrong Kenneth C
• Kay Matthew W
• Mercader Marco A
• Ransbury Terrance J
• Sarvazyan Narine

Classifications

• A61B5/004

  adapted for image acquisition of a particular organ or body part (A61B5/0082 takes precedence; arrangements for optical scanning A61B5/0062) · CPC title

• A61B2034/301

  for introducing or steering flexible instruments inserted into the body, e.g. catheters or endoscopes · CPC title

• A61B90/35

  Supports therefor · CPC title

• A61B5/1459

  invasive, e.g. introduced into the body by a catheter · CPC title

• A61B2018/0212

  using an instrument inserted into a body lumen, e.g. catheter · CPC title